Phosphodiesterase-4 inhibition in COPD Journal Articles

authors

• O'Byrne, Paul
• Gauvreau, Gail

status

• published 

publication date

• August 2009

has subject area

• 11 Medical and Health Sciences (FoR)
• Aminopyridines (MeSH)
• Benzamides (MeSH)
• Bronchodilator Agents (MeSH)
• Cyclic Nucleotide Phosphodiesterases, Type 4 (MeSH)
• Cyclopropanes (MeSH)
• Drug Therapy, Combination (MeSH)
• General & Internal Medicine (Science Metrix)
• Humans (MeSH)
• Patient Selection (MeSH)
• Phosphodiesterase 4 Inhibitors (MeSH)
• Pulmonary Disease, Chronic Obstructive (MeSH)
• Research Design (MeSH)
• Treatment Outcome (MeSH)

published in

• The Lancet  Journal

keywords

• Aminopyridines
• Benzamides
• Bronchodilator Agents
• Cyclic Nucleotide Phosphodiesterases, Type 4
• Cyclopropanes
• Drug Therapy, Combination
• Humans
• Patient Selection
• Phosphodiesterase 4 Inhibitors
• Pulmonary Disease, Chronic Obstructive
• Research Design
• Treatment Outcome

Digital Object Identifier (DOI)

• 10.1016/s0140-6736(09)61538-5

PubMed ID

• 19716944

start page

• 665

end page

• 667

volume

• 374

issue

• 9691